CRT and AstraZeneca Form Major Alliance to Create “Cancer Metabolism” Drugs
Cancer Research UK's commercialisation and development arm, Cancer Research Technology (CRT), today announced it has teamed up with biopharmaceutical business, AstraZeneca, in a major, multi-project alliance, in which around 30 scientists will be focused on creating a stream of new anti-cancer drugs.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.